ULTIMOVACS ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9 NOK | +3.57% |
|
+25.52% | -92.67% |
| 05-07 | Transcript : Ultimovacs ASA, Q1 2024 Earnings Call, May 07, 2024 | |
| 05-07 | Ultimovacs ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ULTIMOVACS ASA | Other Biotechnology & Medical Research | +3.57% | +25.52% | -92.67% | -92.67% | - | 29.45M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ULTI Stock
- Charts Ultimovacs ASA
- Comparison Chart
